This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. This includes technologies that do not rely on the use of human fetal tissue, as described in NOT-OD-19-042. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states.
The purpose of this FOA is to stimulate basic research to develop next-generation human cell-derived assays with improved fidelity to complex human brain, spinal cord, and/or sensory end organ circuit physiology, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system diseases. This FOA is distinct from others that focus on optimization and scalability of assays for compound screening, although projects could, in principle, have utility for late stage evaluation of drug efficacy and toxicity.
Hyperlink for more information:
Filed Under: Featured, Funding Opportunities